Announcements Trials

Browse Landscape

Phase

Phase NA 2 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Completed 212 Terminated 57 Unknown 53 Recruiting 40 Withdrawn 20 Not yet recruiting 20 Active not recruiting 11 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 6 Stomach Neoplasms 5 Melanoma 5 Carcinoma, Non-Small-Cell Lung 5 Neoplasm Metastasis 4 Leukemia, Myeloid, Acute 4 Glioblastoma 4 Breast Neoplasms 4 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Neoplasms 3 Glioma 3 Carcinoma, Renal Cell 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Peritoneal Neoplasms 2 Osteosarcoma 2 Nasopharyngeal Carcinoma 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Mesothelioma, Malignant 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Diffuse Intrinsic Pontine Glioma 2 Warts 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1

Interventions

tucatinib 1 trifluridine tipiracil drug combination 1 Trastuzumab 1 Leucovorin 1 Irinotecan 1 Fluorouracil 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Suspended × Colonic Neoplasms × Clear all

NCT05062889 2026-02-03

ERASE-CRC

Gruppo Oncologico del Nord-Ovest

Phase 2 Suspended

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡